Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.

Area of Science:

• Endocrinology
• Metabolic Disorders
• Hypertension Research

Background:

• Primary aldosteronism (PA) encompasses aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism (IHA), with distinct etiologies.
• The association between PA subtypes and metabolic disorders like obesity, diabetes mellitus, and dyslipidemia requires further clarification.

Purpose of the Study:

• To differentiate obesity and metabolic disorder prevalence between APA and IHA.
• To investigate the underlying pathogenesis of IHA, particularly its link to metabolic factors.

Main Methods:

• Retrospective cross-sectional study using the Japan Primary Aldosteronism Study database.
• Comparative analysis included 516 APA patients, 1015 IHA patients, and 274 essential hypertension (EHT) patients.
• Assessment of obesity, diabetes mellitus, dyslipidemia, and correlations with plasma aldosterone concentrations (PACs).

Main Results:

• IHA patients exhibited significantly higher obesity prevalence than APA and EHT patients, even after adjusting for clinical factors.
• While diabetes mellitus and dyslipidemia prevalences were similar between IHA and APA, IHA patients had higher triglyceride and HbA1c levels.
• No significant correlation was found between metabolic parameters and PACs in either APA or IHA subtypes.

Conclusions:

• Idiopathic hyperaldosteronism (IHA) is associated with a higher tendency for obesity compared to aldosterone-producing adenoma (APA), irrespective of plasma aldosterone concentrations.
• Obesity-related factors are suggested to play a significant role in the pathogenesis of IHA.